Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3439]
News [7988]
Articles [64]
Editorials [9]
Conferences [213]
elearning [49]
Erlotinib dose-adjusted for smoking status effective as first treatment for head and neck cancer
Erlotinib dose-adjusted for smoking status effective as first treatment for head and neck cancer
Possible new pathway can overcome glioblastoma resistance
Possible new pathway can overcome glioblastoma resistance
Drug could delay invasive treatment for low-risk prostate cancer
Drug could delay invasive treatment for low-risk prostate cancer
Investments in new biomarker research
Investments in new biomarker research
Scientists reveal first 3D image of cancer prevention molecule
Scientists reveal first 3D image of cancer prevention molecule
Study showed oxaliplatin improved colon cancer patient survival
Study showed oxaliplatin improved colon cancer patient survival
Glucarpidase approved by FDA
Glucarpidase approved by FDA
Scientists uncover reason for second cancers after targeted melanoma treatment
Scientists uncover reason for second cancers after targeted melanoma treatment
Breast cancer spread triggered by cleaver-wielding protein on cancer cell’s surface
Breast cancer spread triggered by cleaver-wielding protein on cancer cell’s surface
NICE confirms nilotinib for Ph+ chronic myeloid leukaemia patients intolerant or resistant to imatinib
NICE confirms nilotinib for Ph+ chronic myeloid leukaemia patients intolerant or resistant to imatinib

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation